| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |